Cargando…

Perceived risk profile and treatment optimization in heart failure: an analysis from BIOlogy Study to TAilored Treatment in chronic heart failure

BACKGROUND: Achieving target doses of angiotensin‐converting‐enzyme inhibitor/angiotensin‐receptor blockers (ACEi/ARB) and beta‐blockers in heart failure with reduced ejection fraction (HFrEF) is often underperformed. In BIOlogy Study to TAilored Treatment in chronic heart failure (BIOSTAT‐CHF) stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Masatake, Voors, Adriaan A., Ouwerkerk, Wouter, Duarte, Kevin, Girerd, Nicolas, Rossignol, Patrick, Metra, Marco, Lang, Chim C., Ng, Leong L., Filippatos, Gerasimos, Dickstein, Kenneth, van Veldhuisen, Dirk J., Zannad, Faiez, Ferreira, João Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207977/
https://www.ncbi.nlm.nih.gov/pubmed/33960439
http://dx.doi.org/10.1002/clc.23576